Ken Griffin Avrobio, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.15 - $1.48 $89,902 - $115,700	-78,176 Reduced 15.17%	437,040 $559,000
Q4 2023 Feb 14, 2024	BUY	$1.22 - $1.62 $6,384 - $8,477	5,233 Added 1.03%	515,216 $700,000
Q3 2023 Nov 14, 2023	BUY	$0.98 - $1.62 $3,556 - $5,878	3,629 Added 0.72%	509,983 $785,000
Q1 2023 May 15, 2023	SELL	$0.76 - $1.82 $58,227 - $139,439	-76,615 Reduced 13.14%	506,354 $506,000
Q4 2022 Feb 14, 2023	BUY	$0.64 - $0.91 $45,303 - $64,416	70,787 Added 13.82%	582,969 $413,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $1.11 $121,922 - $199,020	-179,298 Reduced 25.93%	512,182 $329,000
Q2 2022 Aug 15, 2022	BUY	$0.75 - $1.33 $55,089 - $97,691	73,452 Added 11.88%	691,480 $636,000
Q1 2022 May 16, 2022	BUY	$1.29 - $4.04 $123,348 - $386,300	95,619 Added 18.3%	618,028 $816,000
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $1.92 Million - $3.38 Million	-557,919 Reduced 51.64%	522,409 $2.01 Million
Q3 2021 Nov 15, 2021	SELL	$5.53 - $9.28 $1.37 Million - $2.29 Million	-247,258 Reduced 18.62%	1,080,328 $6.03 Million
Q2 2021 Aug 16, 2021	SELL	$7.84 - $12.6 $930,208 - $1.49 Million	-118,649 Reduced 8.2%	1,327,586 $11.8 Million
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $2.2 Million - $4.02 Million	-208,472 Reduced 12.6%	1,446,235 $18.4 Million
Q4 2020 Feb 16, 2021	SELL	$12.79 - $17.1 $2.29 Million - $3.06 Million	-178,907 Reduced 9.76%	1,654,707 $23.1 Million
Q3 2020 Nov 16, 2020	SELL	$12.99 - $19.41 $624,416 - $933,019	-48,069 Reduced 2.55%	1,833,614 $23.9 Million
Q2 2020 Aug 14, 2020	SELL	$12.19 - $22.96 $889,833 - $1.68 Million	-72,997 Reduced 3.73%	1,881,683 $32.8 Million
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $2.69 Million - $7.26 Million	266,758 Added 15.8%	1,954,680 $30.4 Million
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $76,264 - $127,866	5,844 Added 0.35%	1,687,922 $34 Million
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $1.07 Million - $1.78 Million	75,931 Added 4.73%	1,682,078 $23.8 Million
Q2 2019 Aug 14, 2019	SELL	$13.21 - $27.29 $89,484 - $184,862	-6,774 Reduced 0.42%	1,606,147 $26.1 Million
Q1 2019 May 15, 2019	BUY	$12.46 - $22.05 $3.12 Million - $5.52 Million	250,266 Added 18.37%	1,612,921 $0
Q4 2018 Feb 14, 2019	SELL	$15.43 - $32.7 $1.99 Million - $4.21 Million	-128,679 Reduced 8.63%	1,362,655 $22.7 Million
Q3 2018 Nov 13, 2018	SELL	$26.95 - $52.7 $8.12 Million - $15.9 Million	-301,380 Reduced 16.81%	1,491,334 $0
Q2 2018 Aug 14, 2018	BUY	$28.08 - $31.2 $38.1 Million - $42.4 Million	1,357,783 Added 312.18%	1,792,714 $51.2 Million
Q2 2018 Aug 10, 2018	BUY	$28.08 - $31.2 $12.2 Million - $13.6 Million	434,931 New	434,931 $0

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account